An official website of the United States government
Home
Name
Zevalin
Alternate Names
IDEC-2B8 (ibritumomab tiuxetan)
IDEC-In2B8 (indium-111-ibritumomab tiuxetan)
IDEC-Y2B8 (Y90-ibritumomab tiuxetan)
Yttrium 90 ibritumomab tiuxetan
Abbreviations
None
Category
Radiation
Subcategory
Radiolabled monoclonal antibody
NSC Number
710085
Primary Site
Lymphoma
Histology
None
Remarks
FDA approved NHL B-cell 2/19/02 Radioimmunotherapy. FDA approved use on non-Hodgkin's lymphoma. IDEC Pharmaceuticals.
Coding
This drug should be coded
